-+ 0.00%
-+ 0.00%
-+ 0.00%

Teva R&D Chief Eric Hughes Steps Down

PUBT·11/18/2026 22:02:02
Teva R&D Chief Eric Hughes Steps Down
  • Teva executive vice president of global R&D and chief medical officer Eric Hughes will leave for a role outside the company.
  • Hughes will remain for the coming months to support the transition.
  • David Gardiner, head of innovative medicines and clinical development, becomes R&D transition lead immediately, reporting to CEO Richard Francis.
  • A search for a permanent successor is beginning immediately.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teva Pharmaceutical Industries Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611181700OMX_____CNEWS_EN_GNW1001304382_en) on November 18, 2026, and is solely responsible for the information contained therein.